𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Binding characteristics of cytotoxic analog of luteinizing-hormone releasing hormone (LH-RH) in membrane from human and MXT mammary cancer

✍ Scribed by Radulović, S.; Milovanović, S; Schally, A.V.

Book ID
122074232
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
152 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of combination treatment with ana
Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters
✍ Karoly Szepeshazi; Karoly Lapis; Andrew V. Schally 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 905 KB

Ductal pancreatic cancers were induced with N-nitrosobis(2-oxopropyl)amine (BOP) in female Syrian golden hamsters. The animals were then treated for 2 months with 5-fluorouracil (5-FU) and with sustained delivery systems of the LH-RH a Onist 'D-Trp-6-LH-RH antagonist (Ac-D-Nal(2)'-D-Phe(~CI)~-D-Pal(

Targeted cytotoxic analog of luteinizing
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice
✍ Kopp�n, Miklos; Nagy, Attila; Schally, Andrew V.; Plonowski, Artur; Halmos, G�bo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

## Background: Receptors for luteinizing hormone-releasing hormone (lh-rh) found in prostate cancers might be used for targeting of chemotherapeutic agents. doxorubicin derivative 2-pyrrolinodoxorubicin (an-201) can be linked to carrier analog [d-lys6]lh-rh to form the targeted cytotoxic analog of